COVID‐19 in DMARD‐treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database

BACKGROUND: To determine whether the use of disease‐modifying antirheumatic drugs (DMARDs) is linked to the risk of COVID‐19 among patients with inflammatory rheumatic diseases (IRDs). METHODS: We performed a disproportionality analysis of the World Health Organization pharmacovigilance database bet...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Fundam Clin Pharmacol
Main Authors: Dernoncourt, Amandine, Schmidt, Jean, Duhaut, Pierre, Liabeuf, Sophie, Gras‐Champel, Valérie, Masmoudi, Kamel, Bennis, Youssef, Batteux, Benjamin
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239613/
https://ncbi.nlm.nih.gov/pubmed/33973280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/fcp.12695
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares